Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Validation of the MENQOL for use with women who have been treated for gynecologic or breast cancer
oleh: Catherine Dolye, Lauran Adams, Alison McAndrew, Stephanie Burlein-Hall, Tracey DasGupta, Jennie Blake, Margaret I. Fitch
Format: | Article |
---|---|
Diterbitkan: | Pappin Communications 2018-07-01 |
Deskripsi
<p class="p1"><span class="s1"><strong>Purpose: </strong>To conduct a psychometric evaluation of the MENQOL, a condition-specific, self-report instrument to assess menopausal symptoms in women with gynecologic and breast cancers.</span></p><p class="p1"><span class="s1"><strong>Methods: </strong>Identify face and content validity of the MENQOL with experts, and reliability and construct validity with a group of women diagnosed with cancer who are suffering from treatment-induced menopause.</span></p><p class="p1"><span class="s1"><strong>Results:</strong> Eighty-two women with treatment-induced menopause completed the MENQOL, EORTC-C30, and the SVQ. The MENQOL was shown to have good face and content validity, and acceptable reliability (homogeneity and test-retest) and validity (concurrent and construct). Additionally, 85.5% of the women reported experiencing hot flashes. However, the most bothersome symptoms were weight gain and fatigue (feeling worn out).</span></p><p class="p1"><span class="s1"><strong>Implications: </strong>The MENQOL can be used to assess treatment-induced menopausal symptoms in women diagnosed with breast or gynecologic cancer.<span class="Apple-converted-space"> </span></span></p>